Indo Us Biotech Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018
INDOUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indo Us Biotech Limited has filed a routine compliance certificate with the stock exchanges for the quarter ended 30 June 2025. The certificate, issued by their Registrar and Share Transfer Agent Bigshare Services Pvt Ltd, confirms that all securities received from depository participants for dematerialization were duly processed and confirmed to the depositories. It also confirms that physical share certificates received for dematerialization were mutilated, cancelled, and the depository's name was substituted as registered owner in the company's register of members within the required 15-day timeline. No new shares were issued, and no financial or operational numbers are disclosed in this filing.
This is a standard quarterly compliance filing with no material impact on the business, financials, or share price. Shareholders do not need to take any action — it only confirms that the company's dematerialization process is functioning as required by SEBI rules.